Document is current
Any future updates will be listed below
-
Authors
Meltsov, Alvin https://orcid.org/0000-0002-9058-0779
Saare, Merli https://orcid.org/0000-0003-0221-2093
Teder, Hindrek https://orcid.org/0000-0001-6608-7979
Paluoja, Priit https://orcid.org/0000-0002-2016-661X
Arffman, Riikka K. https://orcid.org/0000-0003-3277-9293
Piltonen, Terhi https://orcid.org/0000-0002-9921-7300
Laudanski, Piotr https://orcid.org/0000-0001-8955-8198
Wielgoś, Mirosław https://orcid.org/0000-0003-2581-3668
Gianaroli, Luca https://orcid.org/0000-0002-6077-9840
Koel, Mariann https://orcid.org/0000-0001-8567-7296
Peters, Maire https://orcid.org/0000-0003-2063-242X
Salumets, Andres https://orcid.org/0000-0002-1251-8160
Krjutškov, Kaarel https://orcid.org/0000-0003-1297-1464
Palta, Priit https://orcid.org/0000-0001-9320-7008
-
Funding
Funding for this research was provided by:
Enterprise Estonia (EU48695)
Estonian Research Council (PRG1076)
Polish Ministry of Health (grant no. 6/6/4/1/NPZ/2017/1210/1352)
Horizon 2020 innovation grant (ERIN, grant no. EU952516)
EU-FP7 Marie Curie Industry-Academia Partnerships and Pathways (IAPP, grant SARM, EU324509)
- License Information
-
More Information
Article History
Received: 16 May 2023
Accepted: 20 August 2023
First Online: 26 August 2023
Competing interests
: The authors (A.M, M.S, P.Paluoja, H.T, M.P, A.S, P.Palta, K.K) are employed at the Competence Centre on Health Technologies (Tervisetehnoloogiate Arenduskeskus AS) which has developed and implemented beREADY test for clinical usage. A.S, M.K and K.K are the inventors of the TAC-seq technology (European patent No. 17832949.6). The rest of the authors have no interests to disclose.
